Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial. Abstract Text:

V Craig Jordan,

The completion of the Study of Tamoxifen and Raloxifene (STAR) [Vogel VG, Costantino JP, Wickerham DL, et al. The Study of Tamoxifen and Raloxifene (STAR): Report of the National Surgical Adjuvant Breast and Bowel Project P-2 Trial. JAMA 2006;295:2727-2741.] and the ongoing studies with aromatase inhibitors [Goss PE. Breast cancer prevention-clinical trials strategies involving aromatase inhibitors. J Steroid Biochem Mol Biol 2003;86(3-5):487-93.] to assess their worth for the chemoprevention of breast cancer, creates an opportunity to consider the realistic future for chemoprevention as an option for women's healthcare and to identify strategies for future progress in an era of targeted therapeutics, managed healthcare and soaring costs.

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial. Publishing Authors By Initials

VC Jordan,

For similar organic chemicals: hydrocarbons: hydrocarbons, cyclic: hydrocarbons, aromatic: benzene derivatives: benzylidene compounds: stilbenes: tamoxifen research abstracts see: organic chemicals: hydrocarbons: hydrocarbons, cyclic: hydrocarbons, aromatic: benzene derivatives: benzylidene compounds: stilbenes: tamoxifen research

PUBMED ID PMID:

MEDLINE DATE:

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial. Journal Published:

PUBLICATION TYPE: Review

Journal: European journal of cancer (Oxford, England : 1990

VOLUME: 42

Page Numbers: 2909-13

Journal Abbreviation: Eur. J. Cancer

ISSN: 0959-8049

DAY: 24

MONTH: 10

YEAR: 2006

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9005373

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial. Keywords Mesh Terms:

KEYWORDS: Tamoxifen

MESH TERMS: therapeutic use

Chemical & Substance for Abstract: Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial. Information

Substance Name: Raloxifene

Registry Number: 84449-90-1

Grant and Affiliation Information for Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.

AFFILIATION: Fox Chase Cancer Centre, 333 Cottman Avenue, Philadelphia, PA 19111, USA. v.craig.jordan@fccc.edu <v.craig.jordan@fccc.edu>

Country: England

AGENCY: United States NIGMS

GRANT: R01 GM067156

ACRONYM: GM

MEDLINETA: Eur J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene STAR trial Related Publications

• 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
• A laser-temperature-jump method for the study of the rate of transfer of hydrophobic ions and carriers across the interface of thin lipid membranes.
• Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex.
• Androgen-sensitivity of somata and dendrites of spinal nucleus of the bulbocavernosus (SNB) motoneurons in male C57BL6J mice.
• Beyond raloxifene for the prevention of osteoporosis and breast cancer.
• Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells.
• Current noise in transport of hydrophobic ions through lipid bilayer membranes including diffusion polarization in the aqueous phase.
• Development of a one-step immunocapture real-time TaqMan RT-PCR assay for the broad spectrum detection of Pepino mosaic virus.
• Dexamethasone in acute bacterial meningitis.
• Effect of raloxifene on salivary sex steroid concentrations in premenopausal women.
• Effects of the testicular feminization mutation (tfm) of the androgen receptor gene on BSTMPM volume and morphology in rats.
• Function of a conserved loop of the beta-domain, not involved in thiamin diphosphate binding, in catalysis and substrate activation in yeast pyruvate decarboxylase.
• Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis.
• Leaf maximum photosynthetic rate and venation are linked by hydraulics.
• Molecular basis of acute intermittent porphyria.
• Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.
• Origin and evolution of human microRNAs from transposable elements.
• Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain.
• Racial disparity in stage at diagnosis and survival among adults with oral cancer in the US.
• Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation.
• Relationship of limb length inequality with radiographic knee and hip osteoarthritis.
• Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
• SERMs: meeting the promise of multifunctional medicines.
• Spirituality and depressive symptoms in a racially diverse US sample of community-dwelling adults.
• Steroid receptors and their role in the biology and control of breast cancer growth.
• Synthesis with good enantiomeric excess of both enantiomers of alpha-ketols and acetolactates by two thiamin diphosphate-dependent decarboxylases.
• The 1',4'-iminopyrimidine tautomer of thiamin diphosphate is poised for catalysis in asymmetric active centers on enzymes.
• Tuning a potassium channel--the caress of the surroundings.
• Use of polymerase chain reaction as a diagnostic tool for neonatal sepsis can result in a decrease in use of antibiotics and total neonatal intensive care unit length of stay.
• Validity and factor structure of the AUSCAN Osteoarthritis Hand Index in a community-based sample.